You have successfully sign out
Loading...
Cardio Diagnostics Holdings, Inc.
CDIO
Company Description
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Â
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
0.67USD
-0.06Â ( -8.11%)
Relative Strenght
98
Volume Buzz
-80%
Earning Acce
No
Dist 52w H.
76%
